IP Library › Assignment 039682/0212
Patent Assignment
Reel/Frame 039682/0212

Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 039184 Frame 0797. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment Effective 02/01/2016.

Recorded: 2016-08-15 Pages: 19
Assignor
UGP THERAPEUTICS, INC.
Executed: 2016-07-18
Assignee
ENTERIS BIOPHARMA, INC.
83 FULTON STREET, BOONTON, NEW JERSEY, 07005
Covered Properties (19)
Nasal Calcitonin Formulations
Patent: 6,440,392 →
Application: 09/776,537 →
Oral Delivery of Peptides
Patent: 8,088,734 →
Application: 10/761,481 →
Publication: US 2004/0197323
Nasal Calcitonin Formulation
Patent: 40,812 →
Application: 10/774,358 →
Oral delivery of peptide pharmaceutical compositions
Application: 11/144,580 →
Publication: US 2005/0282756
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 8,252,580 →
Application: 11/928,994 →
Publication: US 2008/0102491
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 7,541,174 →
Application: 11/929,028 →
Publication: US 2008/0102509
Bacterial Host Cell for the Direct Expression of Peptides
Patent: 7,553,655 →
Application: 11/929,079 →
Publication: US 2008/0102510
Nasal Calcitonin Formulations
Patent: 43,580 →
Application: 12/459,385 →
Oral Delivery of Peptide Pharmaceutical Compositions
Patent: 8,835,377 →
Application: 13/219,132 →
Publication: US 2012/0328666
Oral Delivery of Peptides
Application: 13/342,133 →
Publication: US 2012/0183582
Anti-Inflammatory Pharmaceutical Products
Patent: 9,102,753 →
Application: 13/524,381 →
Publication: US 2013/0072446
Oral Delivery of Peptide Pharmaceutical Compositions
Patent: 9,504,727 →
Application: 14/484,745 →
Publication: US 2015/0125522
Anti-Inflammatory Pharmaceutical Products
Application: 14/803,426 →
Publication: US 2015/0315256
Nasal calcitonin formulations
Application: 60/180,241 →
Oral delivery of peptides
Application: 60/441,856 →
Oral delivery of peptide pharmaceutical compositions
Application: 60/580,872 →
Anti-Inflammatory Pharmaceutical Products
Application: 61/497,270 →
Nasal Calcitonin Formulation
Application: 90/012,745 →
Nasal Calcitonin Formulation
Application: 95/001,667 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Oct 3, 2008
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC
Reel/Frame 021630/0352 →
Assignment of Assignor's Interest Oct 12, 2011
From: CONSALVO, ANGELO P.; MEHTA, NOZER M.
To: UNIGENE LABORATORIES INC.
Reel/Frame 027049/0839 →
Assignment of Assignor's Interest Oct 12, 2011
From: DALLI, JESMOND
To: UNIGENE LABORATORIES INC.
Reel/Frame 027049/0947 →
Assignment of Assignor's Interest Oct 12, 2011
From: PERRETTI, MAURO
To: UNIGENE LABORATORIES INC.
Reel/Frame 027049/0903 →
Assignment of Assignor's Interest Apr 18, 2012
From: MEHTA, NOZER M.; STERN, WILLIAM; GILLIGAN, JAMES P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 028068/0180 →
Assignment of Assignor's Interest Sep 7, 2012
From: MEHTA, NOZER M.; STERN, WILLIAM; GILLIGAN, JAMES P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 028913/0511 →
Release of Security Interest Sep 7, 2012
From: VICTORY PARK MANAGEMENT
To: UNIGENE LABORATORIES, INC.
Reel/Frame 028913/0370 →
Assignment of Assignor's Interest Sep 12, 2012
From: STERN, WILLIAM
To: UNIGENE LABORATORIES INC.
Reel/Frame 028947/0938 →
Security Agreement Oct 4, 2012
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC, AS COLLATERAL AGENT
Reel/Frame 029074/0689 →
Assignment of Assignor's Interest Apr 17, 2013
From: CONSALVO, ANGELO P.; MEHTA, NOZER M.; PERRETTI, MAURO; DALLI, JESMOND
To: UNIGENE LABORATORIES INC.
Reel/Frame 030234/0359 →
Assignment of Assignor's Interest Jul 23, 2013
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 030856/0340 →
Assignment of Assignor's Interest Feb 20, 2015
From: MEHTA, NOZER M.; STERN, WILLIAM; GILLIGAN, JAMES P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 034992/0301 →
Assignment of Assignor's Interest Jul 5, 2016
From: CONSALVO, ANGELO P; MEHTA, NOZER M; PERRETTI, MAURO; DALLI, JESMOND
To: UNIGENE LABORATORIES INC.
Reel/Frame 039076/0398 →
Assignment of Assignor's Interest Jul 18, 2016
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 039182/0406 →
Assignment of Assignor's Interest Jul 19, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039184/0797 →
Nunc Pro Tunc Assignment Mar 30, 2017
From: ENTERIS BIOPHARMA, INC.
To: RESOTHER PHARMA APS
Reel/Frame 041798/0689 →
Assignment of Assignor's Interest Dec 11, 2018
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 047739/0437 →
Release of Security Interest Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0762 →
Release of Security Interest Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0799 →
Security Interest Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Release of Security Interest Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →